RSS Items

Fezolinetant appeared effective and safe in this population through 24 weeks.

In patients with Binet stage A disease and risk factors for early progression, ibrutinib was associated with delayed onset of symptoms but no survival benefit.

Studies suggest that a longer interval would be reasonable, especially in people at lower risk.

Direct-acting oral anticoagulant monotherapy was superior to dual antithrombotic therapy in a randomized trial.

These findings argue against providing testosterone supplementation for men with age-related declining testosterone levels.

In HIV and ID Observations, Dr. Paul Sax shares what he learned while completing a stint doing inpatient ID consults.

Treating inpatients who had asymptomatic BP elevations was associated with risk for acute kidney injury, myocardial infarction, stroke, or death.

In patients with hip fracture and an elevated troponin level, rapid surgical intervention was associated with lower mortality.

An exploratory analysis of randomized data demonstrates higher mortality and less clear benefit of mAFP use in older patients with STEMI-related cardiogenic shock.

In HIV and ID Observations, Dr. Paul Sax comments on the MMWR not going out for the first time in its more than 60-year history.